RSTV: SCIENCE MONITOR 22.05.2021

      Scientists at DRDO-INMAS develop the first anti-COVID therapeutic application of 2DG: An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO. Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and …